Difference between revisions of "Insulin-like growth factor-binding protein-1"
m |
m |
||
Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
− | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
Line 44: | Line 44: | ||
| Upon transglutaminase action IGFBP-1 forms multimers and this cause the loss of binding affinity to IGF-1 | | Upon transglutaminase action IGFBP-1 forms multimers and this cause the loss of binding affinity to IGF-1 | ||
|- | |- | ||
− | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] |
Latest revision as of 11:45, 10 March 2015
Insulin-like growth factor-binding protein-1 | |
---|---|
Substrate peptide name | Insulin-like growth factor-binding protein-1 |
Synonyms | IGFBP-1 |
Determination type | In vitro |
Source | Homo sapiens |
Subcellular localization | Extracellular fluids |
Swissprot ID | P08833 |
Reactive glutamines | Q66, Q67 |
Reactive lysines | Not determined yet |
Substrate sequence | ALPGEQQPLHAL |
Structure | No available crystal structure |
Surface accessibility | |
Disorder prediction | IUPred |
Reference | PMID:11121406 |
Notes | Upon transglutaminase action IGFBP-1 forms multimers and this cause the loss of binding affinity to IGF-1 |